Potential Anticancer, Anti-inflammatory, and Antioxidant Effects of Dutasteride on LNCap Prostate Cancer Cell Line
Medical Journal of Babylon · 2026-01 · 23 (1) · 172-178
DOI: 10.4103/mjbl.mjbl_884_23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Journal of Babylon, online erschienen am 30.04.2026. Verfasst von Zahraa Abdulhasan Jihad und 2 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Prostate cancer (PCa) is one of the main causes of death in men across the world. Particular focus has been placed on its preventative and treatment techniques, which include focusing on the activity of 5-alpha reductase enzyme which is responsible for the conversion of testosterone to dihydrotestosterone. These androgens are essential for prostatic development and function as well as for cells’ proliferation and survival.
Objective
The aim of this study was to evaluate the anti-proliferative, antioxidant, and anti-inflammatory effects of dutasteride alone or in combination with doxorubicin on the androgen-sensitive prostate cancer cell line LNCap. Materials and Methods: LNCap cells were incubated with dutasteride alone or combination of dutasteride with doxorubicin. MTT [3-(4,5 dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide] assay, caspase 3, tumor necrosis factor (TNF)-alpha, and total anti-oxidant capacity were assessed after 48 h to evaluate anti-proliferative, apoptotic, anti-inflammatory, and anti-oxidant effects of dutasteride.
Results
Dutasteride alone decreased cells viability and TNF-alpha and increased caspase 3 and total anti-oxidant capacity in LNCap cells. The combination of dutasteride with doxorubicin showed synergistic effects on cell viability, caspase 3, and TNF-alpha with no significant effects on total antioxidant capacity in LNCap cells.
Conclusion
Dutasteride alone has anti-proliferative effects with apoptotic, anti-inflammatory and anti-oxidant effects on LNCap cells but when combined with doxorubicin the anti-oxidant effects of dutasteride decreased and other properties increased.
Zitieren
APA
Jihad, Z. A., Abbas, M. K., & Madlum, K. N. (2026). Potential Anticancer, Anti-inflammatory, and Antioxidant Effects of Dutasteride on LNCap Prostate Cancer Cell Line. Medical Journal of Babylon, 23(1), 172-178. https://doi.org/10.4103/mjbl.mjbl_884_23
Vancouver
Jihad ZA, Abbas MK, Madlum KN. Potential Anticancer, Anti-inflammatory, and Antioxidant Effects of Dutasteride on LNCap Prostate Cancer Cell Line. Medical Journal of Babylon. 2026;23(1):172-178. doi:10.4103/mjbl.mjbl_884_23
BibTeX
@article{Jihad2026,
author = {Jihad, Zahraa Abdulhasan and Abbas, Majid Kadhim and Madlum, Kaiser N.},
title = {Potential Anticancer, Anti-inflammatory, and Antioxidant Effects of Dutasteride on LNCap Prostate Cancer Cell Line},
journal = {Medical Journal of Babylon},
year = {2026},
volume = {23},
number = {1},
pages = {172--178},
doi = {10.4103/mjbl.mjbl_884_23}
}
EUVIMED